Corvus Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Corvus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Corvus Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corvus Pharmaceuticals by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $262k | 50k | 5.28 |
2024-06-30 | $17k | 9.2k | 1.82 |
2024-03-31 | $94k | 53k | 1.78 |
2023-12-31 | $1.2k | 679 | 1.76 |
2023-09-30 | $102k | 70k | 1.46 |
2023-06-30 | $2.8k | 1.2k | 2.29 |
2023-03-31 | $999 | 1.2k | 0.83 |
2022-12-31 | $999 | 1.2k | 0.83 |
2022-06-30 | $2.0k | 2.0k | 1.02 |
2022-03-31 | $9.0k | 5.5k | 1.64 |
2021-12-31 | $10k | 4.1k | 2.44 |
2019-06-30 | $226k | 67k | 3.39 |
2019-03-31 | $672k | 167k | 4.02 |
2018-12-31 | $842k | 229k | 3.67 |
2018-09-30 | $1.0M | 118k | 8.65 |
2018-06-30 | $1.3M | 115k | 11.01 |
2018-03-31 | $2.5M | 218k | 11.53 |
2017-12-31 | $2.6M | 246k | 10.42 |
2017-06-30 | $4.0M | 333k | 12.11 |
2017-03-31 | $3.2M | 154k | 20.78 |
2016-12-31 | $2.6M | 180k | 14.29 |
2016-09-30 | $2.7M | 165k | 16.45 |
2016-06-30 | $2.5M | 175k | 14.26 |